Literature DB >> 18941798

Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery.

Susan M Fowler1, Valentina Kon, Lijun Ma, William O Richards, Agnes B Fogo, Tracy E Hunley.   

Abstract

Obesity-related glomerulopathy (ORG) is a secondary form of focal and segmental glomerulosclerosis (FSGS) occurring in severely obese patients. A significant percentage of individuals with ORG will develop renal insufficiency or end stage renal disease. We report here a 17-year-old girl with morbid obesity (body mass index 56.8 kg/m(2)) and ORG presenting with nephrotic range proteinuria, who failed to improve following treatment with diet, exercise and angiotensin-converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) therapy. Laparoscopic gastric bypass surgery was performed, and within 2 weeks following the surgery, the patient had lost 5.7 kg body weight and showed a remarkable decrease in protein excretion to one tenth of pre-surgery levels. More than 1 year after surgery, the patient's urine protein and kidney function have remained normal while off renin-angiotensin system inhibition therapy. This is the first report of successful use of gastric bypass surgery for obesity-related glomerulopathy in an adolescent. We propose that gastric bypass surgery be considered for patients with ORG.

Entities:  

Mesh:

Year:  2008        PMID: 18941798     DOI: 10.1007/s00467-008-1024-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

1.  Plasma angiotensinogen concentrations in obese patients.

Authors:  S Umemura; N Nyui; K Tamura; K Hibi; S Yamaguchi; M Nakamaru; T Ishigami; M Yabana; M Kihara; S Inoue; M Ishii
Journal:  Am J Hypertens       Date:  1997-06       Impact factor: 2.689

2.  The nephrotic syndrome: a complication of massive obesity.

Authors:  J R Weisinger; R L Kempson; F L Eldridge; R S Swenson
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

3.  Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study.

Authors:  David S Freedman; Zuguo Mei; Sathanur R Srinivasan; Gerald S Berenson; William H Dietz
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

4.  Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis.

Authors:  M Praga; E Hernández; E Morales; A P Campos; M A Valero; M A Martínez; M León
Journal:  Nephrol Dial Transplant       Date:  2001-09       Impact factor: 5.992

5.  High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects.

Authors:  Barbara Salani; Lucia Briatore; Gabriella Andraghetti; Gian Franco Adami; Davide Maggi; Renzo Cordera
Journal:  Obesity (Silver Spring)       Date:  2006-09       Impact factor: 5.002

6.  Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis.

Authors:  A Fogo; E P Hawkins; P L Berry; A D Glick; M L Chiang; R C MacDonell; I Ichikawa
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

7.  Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis.

Authors:  A Fogo; I Ichikawa
Journal:  Am J Kidney Dis       Date:  1991-06       Impact factor: 8.860

8.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

9.  Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators.

Authors:  R Cooper; T Forrester; O Ogunbiyi; J Muffinda
Journal:  J Hypertens       Date:  1998-05       Impact factor: 4.844

10.  Adiponectin regulates albuminuria and podocyte function in mice.

Authors:  Kumar Sharma; Satish Ramachandrarao; Gang Qiu; Hitomi Kataoka Usui; Yanqing Zhu; Stephen R Dunn; Raogo Ouedraogo; Kelly Hough; Peter McCue; Lawrence Chan; Bonita Falkner; Barry J Goldstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

View more
  28 in total

Review 1.  Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.

Authors:  Jordana B Cohen; Debbie L Cohen
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

Review 2.  Bariatric surgery and renal function.

Authors:  Andrew Currie; Andrew Chetwood; Ahmed R Ahmed
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

3.  Histological deterioration of obesity-related glomerulopathy despite the loss of proteinuria with weight reduction.

Authors:  Helen Georgaki-Angelaki; Nikolaos Stergiou; Nina Manolaki; Lydia Nakopoulou; Vassiliki P Syriopoulou; Eleftheria Roma-Giannikou
Journal:  Pediatr Nephrol       Date:  2010-02-20       Impact factor: 3.714

4.  The effects of weight change on glomerular filtration rate.

Authors:  Alex Chang; Tom H Greene; Xuelei Wang; Cynthia Kendrick; Holly Kramer; Jackson Wright; Brad Astor; Tariq Shafi; Robert Toto; Julia Lewis; Lawrence J Appel; Morgan Grams
Journal:  Nephrol Dial Transplant       Date:  2015-06-17       Impact factor: 5.992

5.  Proteinuria rebound in IgA nephropathy associated with obesity-related glomerulopathy.

Authors:  Hiro Matsukura; Masako Sakakibara; Izumi Sakamoto; Miho Tatematsu
Journal:  CEN Case Rep       Date:  2015-12-11

Review 6.  Is obesity a risk factor for chronic kidney disease in children?

Authors:  Sujana S Gunta; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2012-11-14       Impact factor: 3.714

7.  Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy.

Authors:  Cuifang Wang; Bing He; Dongxu Piao; Ping Han
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

8.  Can childhood obesity influence later chronic kidney disease?

Authors:  Lyda Jadresic; Richard J Silverwood; Sanjay Kinra; Dorothea Nitsch
Journal:  Pediatr Nephrol       Date:  2018-11-10       Impact factor: 3.714

9.  Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass.

Authors:  Thomas H Inge; Todd M Jenkins; Meg Zeller; Lawrence Dolan; Stephen R Daniels; Victor F Garcia; Mary L Brandt; Judy Bean; Kimberlee Gamm; Stavra A Xanthakos
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

10.  Adiponectin promotes functional recovery after podocyte ablation.

Authors:  Joseph M Rutkowski; Zhao V Wang; Ae Seo Deok Park; Jianning Zhang; Dihua Zhang; Ming Chang Hu; Orson W Moe; Katalin Susztak; Philipp E Scherer
Journal:  J Am Soc Nephrol       Date:  2013-01-18       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.